AU Stock MarketDetailed Quotes
ACW Actinogen Medical Ltd
- 0.025
- -0.001-3.85%
20min DelayMarket Closed Nov 19 16:00 AET
77.07MMarket Cap-4166P/E (Static)
0.027High0.025Low3.20MVolume0.027Open0.026Pre Close83.82KTurnover0.09952wk High0.15%Turnover Ratio3.08BShares0.02052wk Low-0.006EPS TTM54.63MFloat Cap1.777Historical HighLossP/E (Static)2.19BShs Float0.007Historical Low-0.006EPS LYR7.69%Amplitude--Dividend TTM4.17P/B1Lot Size--Div YieldTTM
About Actinogen Medical Ltd Company
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Company Profile
SymbolACW
Company NameActinogen Medical Ltd
Founded1999
MarketASX
Fiscal Year Ends06-30
Address109 Pitt Street Level 9, Suite 901
CitySydney
CountryAustralia
Zip Code2000
Phone+61 289647401
Websitehttps://www.actinogen.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- Steven Gourlay
- Executive Director, Chief Executive Officer and Managing Director
- --
- Jeff Carter
- Chief Financial Officer
- --
- Dana Hilt
- Chief Medical Officer
- --
- Tamara Miller
- Senior Vice President - Product Development
- --
- Geoffrey E.D Brooke
- Non-Executive Chairman of the Board
- --
- Nicki Vasquez
- Non-Executive Director
- --
- Malcolm John McComas
- Non-Executive Director
- --
- George Morstyn
- Non-Executive Director
- --
- Peter Webse
- Company Secretary
- --
- Fujun Li
- Head of Manufacturing
- --
- Michael Roberts
- Investor Relations
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data